UK must reform drug pricing to become life sciences superpower, says GSK boss
Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolved GSK’s outgoing chief executive, Emma Walmsley, has said Britain will struggle to be a “life sciences superpower” unless it overhauls drug pricing. As ministers draw up proposals to increase the amount (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=62ff299a877594b4658abde8491c6c50, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=f0b69c249ada89c32944af8f798627dc, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=476a326e6903722c3b51cbecaa71d84b
The Guardian (South&CentralAsia)
Netherlands braced for exit poll in parliamentary election – Europe live
29/10/2025
Liverpool v Crystal Palace : Carabao Cup – live
29/10/2025
MPs want clarity over Prince Andrew’s ‘peppercorn’ rent at Royal Lodge
29/10/2025
Louvre suspects ‘partially admit’ their role in jewel heist
29/10/2025
The Guardian view on hospices : investment in end-of-life care is a national priority | Editorial
29/10/2025
The Guardian view on Argentina’s election : one step closer to becoming a Trumpian client state | Ediorial
29/10/2025